Magnera (FRA:W2B) Other Financing: €17 Mil (TTM As of Sep. 2025)


FRA:W2B Magnera Corp FRA:W2B
49 GF Score
Price €10.80
GF Value €4.78
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Magnera Other Financing?

Magnera FRA:W2B -0.92% 49 Other Financing is €17 Mil as of Sep. 2025. GuruFocus rates FRA:W2B with a GF Score™ of 49/100 and a GF Value™ of €4.78 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Magnera's Other Financing for the three months ended in Sep. 2025 was €1 Mil.

Magnera's Other Financing for the trailing twelve months (TTM) ended in Sep. 2025 was €17 Mil.

Magnera Other Financing Historical Data

* Premium members only.

The historical data trend for Magnera's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Magnera Other Financing Chart

Magnera Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Sep25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.15 -9.27 -2.40 -10.94 15.34

Magnera Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 17.19 0.93 -1.73 0.85
FRA:W2B
49GF Score
Magnera Corp FRA:W2B
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Magnera Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €17 Mil mean?
Magnera (FRA:W2B) has a Other Financing of €17 Mil as of Sep. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Magnera and its competitors.
Is Magnera's Other Financing too high?
Magnera's current Other Financing is €17 Mil. Overall, Magnera has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Magnera's Other Financing compare to HNST and NUS?
Magnera's Other Financing of €17 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Consumer Packaged Goods company?
A good Other Financing depends on the Consumer Packaged Goods industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Magnera and its competitors. Magnera's current Other Financing is €17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Magnera stock overvalued right now?
Based on GuruFocus' analysis, Magnera (FRA:W2B) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.78, compared to a current price of €10.80 — trading 125.9% above its estimated fair value. The current Other Financing is €17 Mil. Magnera's overall GF Score™ is 49/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Magnera (FRA:W2B), the current Other Financing is €17 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Magnera (FRA:W2B) Overvalued in 2026?

Based on GuruFocus' analysis, Magnera stock appears to be overvalued. The current stock price of €10.80 is trading 125.9% above its estimated GF Value™ of €4.78. GuruFocus considers Magnera to be Significantly Overvalued.

Key valuation signals for FRA:W2B:

  • Other Financing: €17 Mil
  • GF Value™: €4.78 vs. price of €10.80 (125.9% above fair value)
  • GF Score™: 49/100 with 8 warning signs

No single metric tells the full story. See the FRA:W2B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Magnera Business Description

Other Exchanges MAGN:USA
Address 9335 Harris Corners parkway, Suite 300, Charlotte, NC, USA, 28269
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.
49GF Score

Get the complete analysis for FRA:W2B

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80
Price
€4.78
GF Value